Multimodality imaging in the evaluation of cardiovascular manifestations of malignancy
- PMID: 21490697
- PMCID: PMC3066556
- DOI: 10.4061/2011/378041
Multimodality imaging in the evaluation of cardiovascular manifestations of malignancy
Abstract
Up to one third of the population will die as a direct result of cancer. Accurate and timely diagnosis of disease often requires multiple different approaches including the use of modern imaging techniques. Prompt recognition of adverse consequences of some anti-cancer therapies also requires a knowledge of the optimum imaging strategy for the problem at hand. The purpose of this article is to review not only some of the commoner cardiovascular manifestations of malignancy but also to discuss the strengths, weaknesses and appropriate use of cardiovascular imaging modalities.
Figures








Similar articles
-
Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.Otolaryngol Head Neck Surg. 2017 Sep;157(2_suppl):S1-S30. doi: 10.1177/0194599817722550. Otolaryngol Head Neck Surg. 2017. PMID: 28891406
-
Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):459-460n. doi: 10.1093/ehjci/jex154. Eur Heart J Cardiovasc Imaging. 2018. PMID: 29029074
-
Sepsis Care Pathway 2019.Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019. Qatar Med J. 2019. PMID: 31763206 Free PMC article.
-
Role of multimodality imaging in the diagnosis and management of cardiomyopathies.Arch Cardiovasc Dis. 2019 Oct;112(10):615-629. doi: 10.1016/j.acvd.2019.07.004. Epub 2019 Oct 10. Arch Cardiovasc Dis. 2019. PMID: 31607558 Review.
-
Differentiating Rheumatoid and Psoriatic Arthritis of the Hand: Multimodality Imaging Characteristics.Radiographics. 2020 Sep-Oct;40(5):1339-1354. doi: 10.1148/rg.2020200029. Epub 2020 Jul 31. Radiographics. 2020. PMID: 32735474 Review.
Cited by
-
Direct Left Ventricular Metastasis Reduction: 3D-Echo Monitoring For Management of Clinical Case.J Cardiovasc Echogr. 2013 Jul-Sep;23(3):84-87. doi: 10.4103/2211-4122.123955. J Cardiovasc Echogr. 2013. PMID: 28465891 Free PMC article.
References
-
- Klein GJ, Thirion JP. Cardiovascular imaging to quantify the evolution of cardiac diseases in clinical development. Biomarkers. 2005;10(supplement 1):S1–S9. - PubMed
-
- Del Castillo SV, Aguilar Torres R, Paré Bardera JC. Update on cardiac imaging techniques: echocardiography, cardiac magnetic resonance, and multidetector computed tomography. Revista Espanola de Cardiologia. 2009;62(supplement 1):129–150. - PubMed
-
- Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography. Journal of the American College of Cardiology. 2007;50(2):187–204. - PubMed
-
- Rao G, Sajnani N, Kusnetzky LL, Main ML. Appropriate use of transthoracic echocardiography. American Journal of Cardiology. 2010;105(11):1640–1642. - PubMed
-
- Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Journal of the American College of Cardiology. 2006;48(3):e1–e148. - PubMed
LinkOut - more resources
Full Text Sources